Printer Friendly

Chemical Composition and Cytotoxic and Antibacterial Activities of the Essential Oil of Aloysia citriodora Palau Grown in Morocco.

1. Introduction

The genus Aloysia belongs to the Verbenaceae family and consists of approximately 200 species of herbs, shrubs, and small trees which are often aromatic [1]. The species Aloysia citriodora Palau or Lippia citriodora (H.B. & K.) is commonly known as Lemon Verbena, Verbena grass Louise, Arabic tea, and lemongrass. This plant is growing spontaneously in South America, especially in Argentina and Chile. In Morocco, this species is cultivated for more than a century and has been used in folk medicine as herbal tea preparations, for its antispasmodic, digestive, stomachic, sedative, and antipyretic properties. The essential oil extracted from the dried leaves of A. citriodora is indicated for anxiety, stress, insomnia, some depressions, nervous fatigue, multiple sclerosis, psoriasis, tachycardia, rheumatism, enterocolitis, Crohn's disease, anorexia, dyspepsia, intestinal parasites (amebiasis and amebic cysts), and prevention of asthma attacks [2-4]. The broad range of biological activities of essential oils could be generally correlated to the chemical composition. Therefore, this biological difference can be partly explained by the variation in their chemical composition [5]. It is well established that sesquiterpenoids and their derivatives are credited with many biological activities such as anti-inflammatory, antibacterial, antiasthmatic, and antifungal properties [6]. Thus, structure-activity relationships describe broad classes of activities for the different chemical groups of molecules found in essential oils.

In the present study, we analyzed the chemical composition analysis; the cytotoxic and the antibacterial activities of essential oil of A. citriodora distilled from the shade-dried leaves harvested in the summer season (July-August 2015) in different Moroccan regions.

2. Material and Methods

2.1. Plant Material. The leaves of A. citriodora Palau were collected during July-August 2015 (the period of maximum essential oils production) [7], from the following Moroccan regions: Marrakech (Ait Imour region), Beni Mellal (Laayayta locality), Agadir (Oulad Tayma), and Berkane and Demnate (mountain region). The plants were grown in organic farming without pesticide treatments. The botanical determination was performed by Pr. A. Boulli (Laboratory of Natural Resources Valorization, Faculty of Science and Technology, Beni Mellal), and a voucher specimen was deposited in the Herbarium at the Faculty of Science and Technology, Beni Mellal, Morocco, under reference: FSTBMCOLL72015.

2.2. Extraction of the Essential Oil. The collected leaves of A. citriodora Palau were shade-dried during two weeks. Then the essential oil was obtained by hydrodistillation using a Clevenger-type device (samples were 100 g of crushed leaves in 1.51 distilled water). At the end of the distillation process, the organic phase which contains the essential oil is separated from the hydrosol (aqueous phase) with ether followed by gentle removal of the solvent by evaporation. The yield of essential oil ranged from 0.1% to 0.2%.

2.3. GC-MS. The obtained essential oil samples were analyzed with a gas chromatograph Trace GC Ultra equipped with a FID detector and a capillary column (30 m x 0.25 mm, 0.25 [micro]m film thickness) DB-5 (methyl polysiloxane with 5% phenyl); the injection volume was 1 [micro]L. The gas chromatograph was coupled to a mass spectrometer Q Polaris MS that performs the analysis of the mass spectrometry (70 eV with an ion trap). The temperature program was 40[degrees]C for 2 min and then heated to 180[degrees]C at a rate of 4[degrees]C/min. The carrier gas was helium (1.4 ml/min).

2.4. Cytotoxicity Assay. The cytotoxic effect of essential oils was evaluated against P815 (Murine Mastocytoma, cell line), MCF7 (human breast adenocarcinoma), and VERO (kidney carcinoma cell line of monkey). The used cell lines were obtained as a gift of Professor G. Lemaire, Institute of Biochemistry, University of Paris XI, France. PBMCs were isolated using the standard Ficoll-Hypaque density gradient from samples of healthy volunteers under medical supervision. These cells were maintained and grown in special culture medium (RPMI-1640, Sigma-Aldrich, France) supplemented with 10% heat inactivated fetal calf serum (FCS) and 1% penicillin-streptomycin (Sigma-Aldrich). Cultures were maintained at 37[degrees]C in humidified 5% C[O.sub.2] incubator. The cytotoxicity assays were performed in triplicate on each cell line using the MTT [3-(4,5-dimethylthiazol-2-yl)2,5- diphenyltetrazolium bromide] assay (Sigma-Aldrich), as described and modified by Mosmann [8] and Mouse et al. [9].

All experiments were performed with twice PBS washed cells at a density of about 1.5 x [10.sup.4] cells per well (1.5 x [10.sup.5] cells/ml), in flat-bottomed 96-well microtiter plates (Thermo Fisher Scientific) in 100 [micro]l complete medium per well. Then 100 [micro]l of complete culture medium containing different concentrations of the tested essential oils (dissolved in DMSO) was added to each well. After 48 h exposure of cells to these concentrations of tested essential oils at 37[degrees] C and 5% C[O.sub.2], 100 [micro]l of medium was carefully aspirated from each well and replaced with 20 [micro]l of MTT solution (5 mg/ml of PBS). After incubation in the same conditions for 4 hours, the plates were treated with 80 [micro]l of an HCl/isopropanol (24 : 1) solution to dissolve the blue intracellular formazan produced by living cells. One hour later, the absorbance (optical density OD) of the plates was determined by a Multiskan EX spectrophotometer reader at two wavelengths (540 and 630 nm). DMSO (0.5%) was used as the negative control and methotrexate (MTX) as the positive one.

The viability was evaluated by the following formula:

% Viability = (OD/[OD.sub.0]) x 100. (1)

OD is the optical density of the solution in wells containing cells treated with essential oils and [OD.sub.0] is the optical density of the solution in wells containing DMSO treated cells (negative control). The test was performed in triplicate. The [IC.sub.50] values were graphically determined using the Microsoft excel 2013 edition.

2.5. Bacterial Culturing Conditions. The bacterial strains (E. coli ATCC 25922, S. aureus ATCC 25923, and P. aeruginosa ATCC 27853) have been kindly provided by the Laboratory of Bioprocess and Biointerface of the Faculty of Sciences and Technology of Beni Mellal, Morocco. These bacteria were maintained by subculture on Mueller-Hinton nutrient agar medium.

2.5.1. Disc Diffusion Assay. The determination of inhibition diameters of essential oils on E. coli ATCC 25922, S. aureus ATCC 25923, and P. aeruginosa ATCC 27853 cultures was carried out (in triplicate) by the agar disc diffusion method according to the NCCLS (the National Committee for Clinical Laboratory Standards), recently called CLSI (Clinical Laboratory Standards Institute) [10]. The Mueller-Hinton agar media in Petri dishes was swabbed with 100 [micro]l of the bacterial suspension [10.sup.8] CFU/ml (0.5 NTU McFarland) and kept for 30 min at 4[degrees]C. Sterile filter paper discs (6 mm in diameter) [11] were soaked with 6 [micro]l essential oil and placed aseptically on the surface of the inoculated Muller-Hinton agar plates. Plates were then incubated at 37[degrees]C for 24 h and the diameters of bacterial growth inhibition zones (in millimeters) were recorded. Standard antibiotic discs (6 mm) were used as positive controls: ceftriaxone (30 [micro]g), of loxacin (5 [micro]g), and blank discs were used as negative control.

2.5.2. MICs and MBCs Determination. The MIC (minimal inhibitory concentration) and MBC (minimal bactericidal concentration) tests were performed (in triplicate) by the broth microdilution method. The essential oils were dissolved in DMSO (Sigma). Serial dilutions (1: 2) from 2.5% (v/v) as the essential oil concentrations to be incubated at 37[degrees] C for 24 h with the bacterial suspensions adjusted to [10.sup.5] CFU/ml in wells of 96-well microplates (Thermo Fisher Scientific). Untreated control (wells containing bacteria with DMSO at a concentration of 1%) was included in the assay.

After incubation, the wells were optical density examined ([OD.sub.600] nm) with a spectrophotometer (Multiskan EX) for bacterial growth.

The MIC was determined as follows:

MIC = [([OD.sub.Untreated control] - [OD.sub.essential oils])/[OD.sub.Untreated control]] x 100. (2)

[OD.sub.essential oils] is the optical density of the suspension in wells containing essential oils treated bacteria and [OD.sub.Untreated control] is the optical density of the suspension in wells containing DMSO (without essential oils) treated bacteria (negative control).

The MIC is defined as the lowest concentration of the essential oil at which the bacteria does not show visible growth.

MBC is defined as the lowest concentration of the essential oil at which incubated microorganisms were completely killed.

2.6. Statistical Analysis. Data were expressed as mean values [+ or -] SEM of three different experiments; each one was performed in duplicate. Statistical significance was determined with the one-way analysis of variance followed by a post hoc Scheffe's test. The differences were considered statistically significant at p < 0.05.

3. Results

3.1. Extraction and Chemical Composition of the Essential Oils. Distilled essential oil of A. citriodora features: appearance (mobile liquid, clear), color (yellow, more or less dark), characteristic odor (lemony, fresh), and density at 20[degrees]C (0.879).

Among 72 peaks revealed by chromatography (Figure 1), 64 peaks (96%) were identified (according to National Institute of Standards and Technology database). Twenty-four among 64 peaks represent 80% of the essential oil compounds (Table 1). Eight peaks were for unknown compounds and probably represent 4% of the essential oils.

Molecules belonging to five biochemical families, namely, sesquiterpenes (Ar-curcumene 12.32%), terpene oxides (caryophyllene oxide 13.68%), sesquiterpenols (spathulenol 12.38%), monoterpene aldehydes (neral 8.07%), and monoterpenols (cis-verbenol 6.28%), constitute 53% of the essential oil's major compounds (Table 2).

3.2. Essential Oils Mediated Cell Cytotoxicity. The assays showed that the essential oil of A. citriodora exerted a dose dependent cytotoxic effect on P815, MCF7, and VERO tumor cell lines with [IC.sub.50] ranging from 6.60 to 79.63 [micro]g/ml. (Figures 2, 3, 4, and 5). However, no cytotoxicity was observed against PBMCs. In fact, the viability was over 80% at the concentration used to induce tumor cell lysis (Figure 6).

3.3. Antibacterial Assays

3.3.1. Disc Diffusion Assay. Inhibition zone diameters of the disc diffusion assays were recorded in Table 3. The results indicate that E. coli ATCC 25922 and S. aureus ATCC 25923 were sensitive to essential oils of A. citriodora, while P. aeruginosa ATCC 27583 was resistant.

3.3.2. Determination of MIC and MBC. The obtained values of MIC and MBC are shown in Table 4. The MIC on E. coli ranged from 2.84 to 3.73 mg/ml for MA and BM essential oils, respectively. S. aureus MICs were 3.51 mg/mL for BM and 3.87 mg/ml for DE essential oils.

4. Discussion

4.1. Chemical Composition Analysis. The chromatographic spectra of different essential oils from different Moroccan regions revealed the same qualitative chemical composition with some quantitative differences. [beta]-spathulenol is the most abundant compound and represents 15% of the essential oil from Berkane region. trans-Caryophyllene oxide prevails in essential oils from all regions with an average rate of 14%. Arcurcumene is found to represent 14% of the essential oils from Beni Mellal and Agadir regions and 11% of those from other regions. Neral represents 10% of the essential oil from Agadir region and 6% to 8% of those from other regions. cis-Verbenol represents nearly 8% of the essential oil from Agadir region and 4% to 6% of other essential oils. Paracymene was only present in the essential oil from Agadir region at 0.02%. [alpha]-muurolene was only found at 0.04% in the essential oils from Beni Mellal and Demnate regions. 8-Cedren-13-ol was not found in the essential oil from Agadir and represented 0.01 to 0.05% of the essential oils from other regions.

The major molecules dominating the chemical composition of essential oils are caryophyllene oxide, [beta]-spathulenol, Ar-curcumene, neral, and cis-verbenol (Table 2). Other products such as [beta]-caryophyllene, isoledene, elemene, 1.8-cineole, copaene, and nerol are also present with variable ratios. Unlikely, limonene and 6-methyl-5-hepten-2-one, which are compounds constantly found in A. citriodora essential oils distilled in Morocco at proportions of 14% for the first and 3% for the second, are present in the studied essential oils in the present work at very low averaging rates of 0.02% to 0.5%. In fact, the compositions of the essential oils depend on the operating (drying, extraction methods) and on the harvest and the storage conditions [12,13].

The chemical composition analysis of our essential oil was dominated mainly by Ar-curcumene (12.32%), caryophyllene oxide (13.68%), and spathulenol (12.38%). Other compounds were reported in the essential oil of Argentina which is rich in ketones (myrcenone 36.50%, [alpha]-thujone 13.10%), while limonene is only at 6.87% [14]. The essential oil from Turkey contains citrals ranging from 17.90% to 27.10% and limonene of 16% [15]. The major compounds of the essential oil of A. citriodora from Portugal were geranial (26.80% to 38.30%), neral (20.80% to 29.60%), and limonene (5.70% to 20.60%) [13].

The main compounds found in the present investigation were different quantitatively and qualitatively from those reported in the literature. The average rate of limonene and geranial was 17% and 9%, respectively, in different essential oils distilled from A. citriodora grown in Morocco (leaves of A. citriodora harvested in May period), whereas the amount of the monoterpene (limonene) is only 0.52% and the terpene aldehyde (geranial) is not detected in the present study. However, the rates of sesquiterpenes ([beta]-caryophyllene, Ar-curcumene, [beta]-elemene, etc.), terpene oxides (caryophyllene oxide), some monoterpene alcohols (cis-verbenol), and sesquiterpene alcohols (spathulenol) were higher in the present studied essential oils [16]. It is interesting to note that limonene, [beta]-caryophyllene, p-cymene, linalool, citral, apinene, and 1.8-cineole are common compounds of essential oils of Lippia sp. and thought to be responsible for specific biological effects and properties attributed to the genus Aloysia [4].

4.2. Cytotoxicity against P815, MCF7, VERO, and PBMCs Cell Lines. Based on the essential oils cytotoxicity ranking [17], the five essential oils studied marked very high cytotoxic effect against P815 (BE essential oil is the most cytotoxic with [IC.sub.50] = 6.60 [micro]g/ml) and high to moderate activity against MCF7 and VERO cell lines (DE essential oil is the most cytotoxic with [IC.sub.50] = 34.72 [micro]g/ml and 32.90 [micro]g/ml, resp.). To the best of our knowledge, there is no previous report about the cytotoxic activity of A. citriodora essential oil. However, the cytotoxic effect of Lippia alba, with its main constituent citral on HeLa and VERO cell lines was reported [18]. The interesting cytotoxicity toward cell lines could be due to the main compounds in the essential oil. Literature reports the induction of apoptosis by citrals (neral and geranial) in chronic lymphoid leukemia by activation of caspase-3 [19, 20]. Moreover, it has also been demonstrated that [beta]-caryophyllene and caryophyllene oxide were also reported to induce apoptosis in tumor cells and exert analgesic, anti-inflammatory, antibacterial, antifungal, and sedative activities [21, 22]. Furthermore, [beta]-elemene and spathulenol were reported as having anticancer activities on human glioblastoma and on MCF7 cancer cell lines [23-25]. Interestingly, no cytotoxic effect of A. citriodora essential oil studied here was observed on Human peripheral blood mononuclear cells (PBMCs).

4.3. Antibacterial Effect. The MIC values (Table 4) showed that the MA and BM essential oils were the most active against E. coli and BM and DE were the most active against S. aureus. In contrast, AG and BE were the least effective on E. coli and on S. aureus, respectively. All the five tested essential oils showed no activity against P. aeruginosa. Other studies have shown that this bacterial strain is naturally resistant to other essential oils. The CMB/MIC ratio (2.14 for E. coli and 2.02 for S. aureus) permitted to qualify the five studied essential oils as bactericidal [26]. Interestingly, it was observable that cytotoxic and antibacterial activities of essential oils were different; for example, MA presented the moderate cytotoxicity but a very strong antibacterial activity. This may be explained by qualitative and quantitative variability of chemical compounds identified in these essential oils and their differential molecular mechanisms.

Generally, the first site of action of essential oils on the bacterial cells is the membranes. This is directly related to the hydrophobicity of the essential oils components. This property ensures and facilitates permeability of membrane phospholipids bilayer to these molecules. The result is a destabilization of the plasma membrane structure and a change in its permeability to ions, protons, and other cellular components [27-30]. In addition to the induced membrane alterations, such molecules can cross the lipid bilayer and interact with intracytoplasmic targets [31]. Given the molecular diversity of the essential oils, it appears more likely that their antibacterial activity results from the combination of several mechanisms, acting synergistically on different cellular targets [32]. In fact, among the dominant molecules in the five studied essential oils, caryophyllene and [beta]-caryophyllene oxide have antibacterial and antifungal activities [33]. Oxygenates (caryophyllene oxide, 1.8-cineole, etc.) have in vitro antibacterial activity [34]; citral (neral and geranial) has a strong antibacterial effect [35]. The interaction between p-cymene, [gamma]-terpinene, and the phenolic compounds could exhibt an antibacterial activity [36]. Furthermore, the essential oils showing high antibacterial activity are phenol and cinnamic aldehyde rich oils (thymol, carvacrol, and eugenol) as in the essential oils of Thymus vulgaris, Origanum compactum, Satureja montana, Eugenia caryophyllata, and Cinnamomum zeylanicum [37]. However, antimicrobial effectiveness of an essential oil is due to the nature and content of these various constituents that may act synergistically; the effect of minor compounds is not always negligible. Synergism between constituents can cause a much more pronounced effect than the expected activity of the major compounds [38].

5. Conclusion

The results obtained in this study showed that the molecular profile of the essential oil of A. citriodora grown in Morocco is slightly variable depending on the region where the plant was harvested. In vitro tested essential oils of A. citriodora have a strong cytotoxic activity against P815 ([IC.sub.50] = 6.60 [micro]g/ml), compared to MCF7 ([IC.sub.50] = 34.72 [micro]g/ml) and VERO ([IC.sub.50] = 32.90 [micro]g/ml). A moderate antibacterial activity on E. coli ATCC 25922 and on S. aureus ATCC 25923 was recorded. However, P. aeruginosa ATCC 27853 strain was resistant to these essential oils. Cytotoxic and antibacterial activities depend on the chemical nature and interactions of A. citriodora essential oil's compounds. Further studies need to be conducted on apoptosis induction, genes expression (Bcl2, p53, Bax, Jun/Fos, etc.), and antitumor activity of the main compounds of A. citriodora essential oil to understand the involved molecular pathways.

Conflicts of Interest

The authors do not have any conflicts of interest regarding the content of the present work.


The authors would like to thank the National Centre for Scientific and Technical Research staff in Rabat, Morocco, for their support and analysis of the samples using GC-MS. They would like also to express their gratitude to the members of the Laboratory of Bioprocess and Biointerfaces directed by Professor Hassan Latrache of the Faculty of Science and Technology of Beni Mellal, Morocco, for their donation of bacterial strains.


[1] F. C. Terblanche and G. Kornelius, "Essential oil constituents of the genus Lippia (verbenaceae)--a literature review," Journal of Essential Oil Research, vol. 8, no. 5, pp. 471-485, 1996.

[2] D. Baudoux, Cahiers Pratiques D'aromatherapie Selon L'ecole Francaise, Grossesse, vol. 5, 2010.

[3] S. El Hawary, M. Yousif, A. Abdel Motaal, and L. Abd-El Hameed, "Composition and bioactivities of the essential oil from Leaves of Lippia citriodora kunth cultivated in Egypt," Journal of Biologically Active Products from Nature, vol. 1, no. 2, pp. 112-119, 2011.

[4] M. E. Pascual, K. Slowing, E. Carretero, D. S. Mata, and A. Villar, "Lippia: traditional uses, chemistry and pharmacology: a review," Journal of Ethnopharmacology, vol. 76, no. 3, pp. 201-214, 2001.

[5] M. T. Baratta, H. J. D. Dorman, S. G. Deans, A. C. Figueiredo, J. G. Barroso, and G. Ruberto, "Antimicrobial and antioxidant properties of some commercial essential oils," Flavour and Fragrance Journal, vol. 13, no. 4, pp. 235-244, 1998.

[6] N. R. Farnsworth and A. S. Bingel, "Problems and prospects of discovering new drugs from higher plants by pharmacological screening," in New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutical Activity, H. Wagner and P. Wolff, Eds., Proceedings in Life Sciences, pp. 1-22, Springer, Berlin, Germany, 1977.

[7] S. L. F. Sarrazin, R. B. Oliveira, L. E. S. Barata, and R. H. V. Mourao, "Chemical composition and antimicrobial activity of the essential oil of Lippia grandis Schauer (Verbenaceae) from the western Amazon," Food Chemistry, vol. 134, no. 3, pp. 1474-1478, 2012.

[8] T. Mosmann, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays," Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55-63, 1983.

[9] H. A. Mouse, M. Tilaoui, A. Jaafari et al., "Evaluation of the in vitro and in vivo anticancer properties of Moroccan propolis extracts," Brazilian Journal of Pharmacognosy, vol. 22, no. 3, pp. 558-567, 2012.

[10] NCCLS/CLSI, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard, National Committee for Clinical Laboratory Standards, Clinical and Laboratory Standards Institute (NCCLS/CLSI), Wayne, Pa, USA, 8th edition, 2002.

[11] L. Jirovetz, G. Eller, G. Buchbauer, and S. G. Pandali, "Chemical composition, antimicrobial activities and odor descriptions of some essential oils with characteristic floral-rosy scent and of their principal aroma compounds," in Recent Research Developments in Agronomy & Horticulture, S. G. Pandalai, Ed., vol. 2, pp. 1-12, Research Signpost, Trivandrum, India, 2006.

[12] C. A. N. Catalan and M. E. P. De Lampasona, "The chemistry of the genus Lippia (Verbenaceae)," in Oregano. The genera origanum and Lippia, S. E. Kintzios, Ed., pp. 127-149, Taylor and Francis, London, UK, 2002.

[13] P. C. Santos-Gomes, M. Fernandes-Ferreira, and A. M. S. Vicente, "Composition of the essential oils from flowers and leaves of vervain [Aloysia triphylla (L' Herit.) Britton] grown in Portugal," Journal of Essential Oil Research, vol. 17, no. 1, pp. 73-78, 2005.

[14] J. A. Zygadlo, A. L. Lamarque, D. M. Maestri et al., "Volatile constituents of Aloysia triphylla (L'Herit.) britton," Journal of Essential Oil Research, vol. 6, no. 4, pp. 407-409, 1994.

[15] T. Ozek, N. Kirimer, K. H. C. Baser, and G. Tumen, "Composition of the essential oil of Aloysia triphylla (L'Herit.) Britton grown in Turkey," Journal of Essential Oil Research, vol. 8, no. 5, pp. 581-583,1996.

[16] J. Bellakhdar, A. I. Idrissi, S. Canigueral, J. Iglesias, and R. Vila, "Composition of lemon verbena (Aloysia triphylla (L'Herit.) Britton) oil of Moroccan origin," Journal of Essential Oil Research, vol. 6, no. 5, pp. 523-526, 1994.

[17] P. M. Doll-Boscardin, A. Sartoratto, B. H. L. de Noronha Sales Maia et al., "In vitro cytotoxic potential of essential oils of Eucalyptus benthamii and its related terpenes on tumor cell lines," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 342652, 8 pages, 2012.

[18] A. C. Mesa-Arango, J. Montiel-Ramos, B. Zapata, C. Duran, L. Betancur-Galvis, and E. Stashenko, "Citral and carvone chemotypes from the essential oils of Colombian Lippia alba (Mill.) N.E. brown: composition, cytotoxicity and antifungal activity," Memorias do Instituto Oswaldo Cruz, vol. 104, no. 6, pp. 878-884, 2009.

[19] L. De Martino, G. D'Arena, M. M. Minervini et al., "Verbena officinalis essential oil and its component citral as apoptotic-inducing agent in chronic lymphocytic leukemia," International Journal of Immunopathology and Pharmacology, vol. 22, no. 4, pp. 1097-1104, 2009.

[20] N. Dudai, Y. Weinstein, M. Krup, T. Rabinski, and R. Ofir, "Citral is a new inducer of caspase-3 in tumor cell lines," Planta Medica, vol. 71, no. 5, pp. 484-488, 2005.

[21] P. Jegajeevanram, N. M. I. Alhaji, and S. Velavan, "Identification of insecticidal components of Mango Ginger rhizome and Tagetes erecta flower extracts by GC-MS analysis," International Journal of Chemical and Pharmaceutical Analysis, vol. 1, no. 4, pp. 203-207, 2014.

[22] E. Amiel, R. Ofir, N. Dudai, E. Soloway, T. Rabinsky, and S. Rachmilevitch, "[beta]-caryophyllene, a compound isolated from the biblical balm of gilead (Commiphora gileadensis), is a selective apoptosis inducer for tumor cell lines," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 872394, 8 pages, 2012.

[23] T. Zhu, Y. Xu, B. Dong et al., "[beta]-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor [beta] and induces sensitization to cisplatin," Oncology Reports, vol. 26, no. 2, pp. 405-413, 2011.

[24] Y. Chen, C. Zhou, Z. Ge et al., "Composition and potential anticancer activities of essential oils obtained from myrrh and frankincense," Oncology Letters,vol. 6, no. 4, pp. 1140-1146,2013.

[25] A. Martins, Z. Hajdu, A. Vasas, B. Csupor-Loffler, J. Molnar, and J. Hohmann, "Spathulenol inhibit the human ABCB1 efflux pump," Planta Medica, vol. 76, no. 12, p. 608, 2010.

[26] G. A. Pankey and L. D. Sabath, "Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections," Clinical Infectious Diseases, vol. 38, no. 6, pp. 864-870, 2004.

[27] J. Sikkema, J. A. de Bont, and B. Poolman, "Mechanisms of membrane toxicity of hydrocarbons," Microbiology and Molecular Biology Reviews, vol. 59, no. 2, pp. 201-222, 1995.

[28] S. D. Cox, C. M. Mann, J. L. Markham et al., "The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil)," Journal of Applied Microbiology, vol. 88, no. 1, pp. 170-175, 2000.

[29] A. Ultee, M. H. J. Bennik, and R. Moezelaar, "The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus " Applied and Environmental Microbiology, vol. 68, no. 4, pp. 1561-1568, 2002.

[30] E. Guinoiseau, A. Luciani, P. G. Rossi et al., "Cellular effects induced by Inula graveolens and Santolina corsica essential oils on Staphylococcus aureus " European Journal of Clinical Microbiology and Infectious Diseases, vol. 29, no. 7, pp. 873-879, 2010.

[31] M. Cristani, M. D'Arrigo, G. Mandalari et al., "Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity," Journal of Agricultural and Food Chemistry, vol. 55, no. 15, pp. 6300-6308, 2007.

[32] S. Burt, "Essential oils: their antibacterial properties and potential applications in foods--a review," International Journal of Food Microbiology, vol. 94, no. 3, pp. 223-253, 2004.

[33] H. J. D. Dorman and S. G. Deans, "Antimicrobial agents from plants: antibacterial activity of plant volatile oils," Journal of Applied Microbiology, vol. 88, no. 2, pp. 308-316, 2000.

[34] G. O. Onawunmi, "Evaluation of the antimicrobial activity of citral," Letters in Applied Microbiology, vol. 9, no. 3, pp. 105-108, 1989.

[35] A. Sivropoulou, E. Papanikolaou, C. Nikolaou, S. Kokkini, T. Lanaras, and M. Arsenakis, "Antimicrobial and cytotoxic activities of Origanum essential oils," Journal of Agricultural and Food Chemistry, vol. 44, no. 5, pp. 1202-1205, 1996.

[36] R. J. W. Lambert, P. N. Skandamis, P. J. Coote, and G.-J. E. Nychas, "A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol," Journal of Applied Microbiology, vol. 91, no. 3, pp. 453-462, 2001.

[37] P. Franchomme, "L'aromatologie a visee anti-infectieuse," Phytomedecine, pp. 25-47, 1981.

[38] R. C. Gueldner, D. M. Wiison, and A. R. Heidt, "Volatiie compounds inhibiting Aspergillus flavus," Journal of Agricultural and Food Chemistry, vol. 33, no. 3, pp. 411-413, 1985.

Moulay Ali Oukerrou, Mounir Tilaoui, Hassan Ait Mouse, Inass Leouifoudi, Abdeslam Jaafari, and Abdelmajid Zyad

Laboratory of Biological Engineering, Natural Substances, Cellular and Molecular Immuno-Pharmacology, Immunobiology of Cancer Cells Cluster, Faculty of Science and Technology, Sultan Moulay Slimane University, Beni Mellal, Morocco

Correspondence should be addressed to Abdelmajid Zyad;

Received 1 March 2017; Revised 24 April 2017; Accepted 11 May 2017; Published 12 June 2017

Academic Editor: Robert Gogal

Caption: FIGURE 1: Chromatograms of A. citriodora essential oils from different regions.

Caption: FIGURE 2: A. citriodora essential oil's cytotoxicity against P815 cell line. AG: Agadir. BM: Beni Mellal. BE: Berkane. DE: Demnate. MA: Marrakech. DMSO: control.

Caption: FIGURE 3: A. citriodora essential oil's cytotoxicity against MCF7 cell line. AG: Agadir. BM: Beni Mellal. BE: Berkane. DE: Demnate. MA: Marrakech. DMSO: control.

Caption: FIGURE 4: A. citriodora essential oil's cytotoxicity against VERO cell line. AG: Agadir. BM: Beni Mellal. BE: Berkane. DE: Demnate. MA: Marrakech. DMSO: control.

Caption: Figure 5: [IC.sub.50] of essential oils of A. citriodora against P815, MCF7, and VERO cell lines. AG: Agadir, BM: Beni Mellal, BE: Berkane, DE: Demnate, and MA: Marrakech. The data shown are the mean values [+ or -] SEM of three different experiments; each one was performed in duplicate. Statistical significance was determined with the one-way analysis of variance followed by a post hoc Scheffe's test. Significance was considered at p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***) compared to control (untreated cell).

Caption: FIGURE 6: Cytotoxicity assay of A. citriodora essential oils from different Moroccan regions on PBMCs. AG: Agadir. BM: Beni Mellal. BE: Berkane. DE: Demnate. MA: Marrakech. DMSO: control.
TABLE 1: Chemical composition after GC-MS analysis of the essential
oils of A. citriodora.

Peak                 Component (a)               RI (b)   % AG (c)

1                   [alpha]-Pinene                909       0.23
2                   [alpha]-Thujene               927       0.09
3                    [beta]-Pinene                964       0.14
4                      Sabinene                   972       0.04
5               6-Methyl-5-hepten-2-one           987       0.03
6                   [beta]-Myrcene                988       0.03
7                  [alpha]-Terpinene              1017      0.12
8                     Paracymene                  1024      0.02
9                      Limonene                   1027      0.71
10                    1,8-Cineole                 1031      1.97
11                cis-[beta]-Ocimene              1037      0.02
12               trans-[beta]-Ocimene             1045      0.04
13                 [gamma]-Terpinene              1054      0.33
14              trans-Sabinene hydrate            1096      0.29
15                    6-Camphenol                 1110      0.08
16                cis-Limonene oxide              1117      0.16
17                Campholene aldehyde             1125      0.58
18             trans-p-Mentha-2,8-dienol          1127      0.18
19            cis-p-Mentha-2,8-dien-1-ol          1131      0.33
20                  trans-Verbenol                1144      0.64
21                   cis-Verbenol                 1153      7.78
22          1,3,4-Trimethyl-3-cyclohexene-        1171      0.70
23           cis-p-Mentha-1(7),8-dien-2-ol        1185      0.13
24               Verbenyl ethyl ether             1186      0.31
25                     2-Carene                   1189      1.71
26                     Myrtenol                   1193      0.58
27                trans-2-Caren-4-ol              1222      0.53
28                     D-Carvone                  1223      0.27
29                    cis-Carveol                 1226      0.06
30                       Nerol                    1228      1.85
31                       Neral                    1242     10.02
32                    Piperitone                  1250      0.15
33          2,6,6-Trimethyl-1-cyclohexene-        1254      0.27
34                 Perillic aldehyde              1257      0.03
35                  para-Cymen-7-ol               1289      0.05
36       8,11,14-Eicosatrienoic acid. (Z.Z.Z)-    1294      0.04
37       1-(1,3-Dimethyl-buta-1.3-dienyl)-3,7,     --       0.03
           7-trimethyl-2-oxa- bicyclo[3.2.0]
38               trans-Carvyl acetate             1342      0.07
39                      Eugenol                   1356      0.19
40                  Geranyl acetate               1365      0.66
41                  [alpha]-Copaene               1375      1.25
42                     Isoledene                  1377      3.48
43        7-Tetracyclo [ (3.8)0(3.9)]       --       0.10
           Undecanol, 4,4,11,11-tetramethyl-
44              Di-epi-[alpha]-cedrene            1412      0.67
45               [beta]-Caryophyllene             1420      3.11
46                     c-Elemene                  1433      2.30
47             trans-[alpha]-Bergamotene          1434      0.09
48                   Aromadendrene                1440      0.06
49                  [alpha]-Humulen               1453      0.6
50                 Alloaromadendrene              1460      1.66
51                   Germacrene-D                 1480      0.28
52                   Ar-curcumene                 1483     11.47
53                  [beta]-Guaiene                1490      0.01
54        Tricyclo[]undecan-3-ol,     1498      0.49
55                 [alpha]-Muurolene              1499       --
56                   c-Himachalene                1505      0.34
57                    Calamenene                  1514      0.09
58        9-Isopropyl-1-methyl-2-methylene-5-     1522      0.05
59                 [gamma]-Cadinene               1523      0.17
60                    c-Cadinene                  1524      3.89
61                [beta]-Spathulenol              1576     13.27
62             trans-Caryophyllene oxide          1580     13.52
63                 Ledene oxide-(I)               1631      1.75
64                  8-Cedren-13-ol                1657       --
65            Alloaromadendrene oxide-(1)         1672      3.06
66            Alloaromadendrene oxide-(2)         1678      0.28
67              Eudesma-4,11-dien-2-ol            1690      0.31
68                  trans-Nuciferol               1727      2.31
69                   cis-Nuciferol                1734      2.17
70          Murolan-3,9(11)-diene-10-peroxy        --       0.36
71                 Ledene oxide-(II)              2062      0.35
72        Tricyclo[]undecan-3-ol,      --       0.97

Peak     % BM (d)   % BE (e)   % DE (f)   % MA (g)   Identification

1          0.39       0.17       0.21       0.20         RI, MS
2          0.14       0.08       0.09       0.08         RI, MS
3          0.14       0.09       0.12       0.09         RI, MS
4          0.05       0.03       0.04       0.04         RI, MS
5          0.02       0.02       0.02       0.02         RI, MS
6          0.02       0.02       0.02       0.04         RI, MS
7          0.10       0.08       0.08       0.09         RI, MS
8           --         --         --         --          RI, MS
9          0.63       0.36       0.5        0.39         RI, MS
10         1.44       1.66       1.41       1.97         RI, MS
11         0.02        --        0.02       0.01         RI, MS
12         0.03       0.05       0.03       0.05         RI, MS
13         0.13       0.15       0.18       0.14         RI, MS
14         0.14       0.17       0.17       0.13         RI, MS
15         0.04       0.05       0.06       0.05         RI, MS
16         0.10       0.14       0.13       0.22         RI, MS
17         0.26       0.4        0.4        0.40         RI, MS
18         0.17       0.16       0.10       0.12         RI, MS
19         0.18       0.20       0.21       0.15         RI, MS
20         0.34       0.47       0.38       0.45         RI, MS
21         4.87       5.22       5.82       4.41         RI, MS
22         0.63       0.59       0.53       0.62         RI, MS

23         0.09       0.14       0.07       0.07         RI, MS
24         0.30       0.24       0.35       0.31         RI, MS
25         0,86       1.11       1.03       0.84         RI, MS
26         0.33       0.36       0.37       0.32         RI, MS
27         0.29       0.43       0.33       0.42         RI, MS
28         0.22       0.26       0.19       0.34         RI, MS
29         0.03       0.04       0.05       0.03         RI, MS
30         2.16       1.56       2.05       1.60         RI, MS
31         7.23       8.57       8.18       6.37         RI, MS
32         0.11       0.14       0.12       0.07         RI, MS
33         0.12       0.19       0.18       0.15         RI, MS

34         0.03       0.02       0.03       0.04         RI, MS
35         0.09       0.13       0.05       0.10         RI, MS
36         0.05       0.03       0.03       0.03         RI, MS
37         0.03       0.03       0.03       0.06         RI, MS

38         0.07       0.07       0.08       0.04         RI, MS
39         0.22       0.20       0.21       0.31         RI, MS
40         1.22       0.91       1.29       1.06         RI, MS
41         1.73       1.27       1.45       2.16         RI, MS
42         4.46       3.89       4.19       4.04         RI, MS
43         0.17       0.12       0.14       0.13         RI, MS

44         0.96       0.67       0.82       0.68         RI, MS
45         3.26       2.77       4.18       1.85         RI, MS
46         3.04       2.77       2.99       2.93         RI, MS
47         0.09       0.08       0.09       0.04         RI, MS
48         0.05       0.06       0.1        0.05         RI, MS
49         0.49       0.59       0.61       0.20         RI, MS
50         1.36       1.02       1.30       1.00         RI, MS
51         0.39       0.29       0.36       0.31         RI, MS
52        13.38      11.28      14.15      11.30         RI, MS
53         0.01       0.02       0.02       0.01         RI, MS
54         0.68       0.56       0.56       0.65         RI, MS

55         0.04        --        0.04        --          RI, MS
56         0.60       0.47       0.46       0.64         RI, MS
57         0.16       0.11       0.12       0.13         RI, MS
58         0.09       0.07       0.08       0.09         RI, MS

59         0.26       0.19       0.23       0.22         RI, MS
60         5.04       4.57       4.99       4.86         RI, MS
61        10.19      15.61       9.42      13.42         RI, MS
62        13.25      14.14      13.28      14.22         RI, MS
63         2.96       2.41       2.25       3.01         RI, MS
64         0.02       0.03       0.01       0.05         RI, MS
65         4.26       4.37       3.79       4.35         RI, MS
66         0.50       0.4        0.4        0.79         RI, MS
67         0.46       0.46       0.45       0.62         RI, MS
68         3.10       2.60       3.10       3.86         RI, MS
69         3.30       2.32       2.80       3.17         RI, MS
70         0.53       0.5        0.48       0.73         RI, MS
71         0.45       0.47       0.45       0.57         RI, MS
72         1.25       1.31       1.33       1.35         RI, MS

(a) Compounds are listed in order of their elution fromaDB-5 column.
(b) Linear retention index taken fromNIST 08, National Institute of
Standards and Technology, Mass Spectral Library (NIST/EPA/NIH). (c)
Essential oil of Agadir. (d) Essential oil of Beni Mellal. (e)
Essential oil of Berkane. (f) Essential oil of Demnate. (g)
Essential oil of Marrakech.

TABLE 2: Main major compounds of essential oil of Aloysia citriodora
analyzed by GC-MS.

Molecules             % AG (a)   % BM (b)   % BE (c)   % DE (d)

trans-Caryophyllene    13.52      13.25      14.14      13.28
[beta]-Spathulenol     13.27      10.19      15.61       9.42
Ar-curcumene           11.47      13.38      11.28      14.15
Neral                  10.02       7.23       8.57       8.18
cis-Verbenol            7.78        --        5.22       5.82

Molecules             % MA (e)

trans-Caryophyllene    14.22
[beta]-Spathulenol     13.42
Ar-curcumene           11.30
Neral                   6.37
cis-Verbenol             --

(a) AG: Agadir. (b) BM: Beni Mellal. (c) BE: Berkane. (d) DE:
Demnate. (e) MA: Marrakech.

TABLE 3: Inhibition zone diameters (mm) of A. citriodora essential
oils on bacterial strains.

                                Inhibition diameter (mm)

Bacterial strains           AG *   BM *   BE *   DE *   MA *

E. coli ATCC 25922           8      10     8      8      10
S. aureus ATCC 25923         8      11     11     11     11
P. aeruginosa ATCC 27853     6      6      6      6      6

                            Inhibition diameter (mm)

Bacterial strains           Ceftriaxone   Ofloxacin

E. coli ATCC 25922              28           32
S. aureus ATCC 25923            25           28
P. aeruginosa ATCC 27853        14           18

* AG: Agadir. BM: Beni Mellal. BE: Berkane. DE: Demnate. MA:

TABLE 4: Minimal inhibitory concentrations (MIC) and minimal
bactericidal concentrations (MBC) of A. citriodora essential oils.

                 MIC and MBC in mg/ml

                        E. coli

              MIC                   MBC

AG *   8.37 [+ or -] 1.27   12.48 [+ or -] 2.27
BM *   3.73 [+ or -] 1.00   7.42 [+ or -] 0.30
BE *   5.24 [+ or -] 0.17   8.49 [+ or -] 0.33
DE *   5.68 [+ or -] 1.25   9.15 [+ or -] 1.53
MA *   2.84 [+ or -] 0.83   10.06 [+ or -] 3.93

                 MIC and MBC in mg/ml

                       S. aureus

              MIC                   MBC

AG *   5.84 [+ or -] 0.44   9.73 [+ or -] 1.81
BM *   3.51 [+ or -] 0.37   9.51 [+ or -] 2.80
BE *   6.42 [+ or -] 0.46   12.12 [+ or -] 1.28
DE *   3.87 [+ or -] 0.36   10.31 [+ or -] 2.79
MA *   4.69 [+ or -] 1.15   7.43 [+ or -] 1.32

* AG: Agadir. BM: Beni Mellal. BE: Berkane. DE: Demnate. MA:
COPYRIGHT 2017 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Oukerrou, Moulay Ali; Tilaoui, Mounir; Mouse, Hassan Ait; Leouifoudi, Inass; Jaafari, Abdeslam; Zyad
Publication:Advances in Pharmacological Sciences
Article Type:Report
Geographic Code:6MORO
Date:Jan 1, 2017
Previous Article:Downregulation of Thromboxane [A.sub.2] Receptor Occurs Mainly via Nuclear Factor-KappaB Signaling Pathway in Rat Renal Artery.
Next Article:Antidiabetic Effects of the Ethanolic Root Extract of Uvaria chamae P. Beauv (Annonaceae) in Alloxan-Induced Diabetic Rats: A Potential Alternative...

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters